Market revenue in 2023 | USD 1.6 million |
Market revenue in 2030 | USD 3.1 million |
Growth rate | 10.1% (CAGR from 2023 to 2030) |
Largest segment | Services |
Fastest growing segment | Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Services, Data Sets |
Key market players worldwide | IQVIA Holdings Inc, International Business Machines Corp, Thermo Fisher Scientific Inc, PAREXEL, PerkinElmer, Icon PLC, Oracle Corp, Syneos Health, Medpace Holdings Inc |
Services was the largest segment with a revenue share of 56.25% in 2023. Horizon Databook has segmented the UAE real world evidence solutions market based on services, data sets covering the revenue growth of each sub-segment from 2018 to 2030.
The United Arab Emirates is one of the fastest-growing markets for RWE in the Middle East. The demand for RWE in the UAE is driven by the growing emphasis on evidence-based medicine, increased healthcare expenditure, and the need to evaluate the effectiveness & safety of healthcare interventions in real-world settings.
Government initiatives, academic institutions, and healthcare providers primarily drive the RWE market in the UAE. The Dubai Health Authority launched several initiatives to promote the use of RWE, including establishing a centralized data platform to collect and analyze healthcare data.
The Abu Dhabi Health Services Company also implemented a similar initiative to develop a comprehensive health information system that can provide real-time data on healthcare delivery. In addition, the private sector is also increasingly investing in RWE in the UAE.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account